Search Results for "Olestyr"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Olestyr. Results 1 to 5 of 5 total matches.
Bempedoic Acid (Nexletol) for Lowering LDL-Cholesterol
The Medical Letter on Drugs and Therapeutics • Apr 06, 2020 (Issue 1595)
Prevalite Lovastatin Nexletol Nexlizet Niacin Olestyr Pitavastatin Praluent Pravachol pravastatin ...
The FDA has approved the oral adenosine triphosphate-citrate
lyase (ACL) inhibitor bempedoic acid for
use alone (Nexletol – Esperion) and in a fixed-dose
combination with the cholesterol absorption inhibitor
ezetimibe (Nexlizet) as an adjunct to diet and maximally
tolerated statin therapy in adults with heterozygous
familial hypercholesterolemia (HeFH) or established
atherosclerotic cardiovascular disease (ASCVD) who
require additional lowering of LDL-cholesterol (LDL-C).
Bempedoic acid is the first ACL inhibitor to be approved
in the US.
Drugs for Rheumatoid Arthritis
The Medical Letter on Drugs and Therapeutics • Nov 15, 2021 (Issue 1637)
prednisone Olestyr Humira Questran Simponi sarilumab salazopyrin Ruxience Riximyo rituximab Rituxan Renflexis ...
Rheumatoid arthritis (RA) is prevalent in 0.5% of
adults in the US; it is about 2.5 times more common
in women than in men. Guidelines for treatment
of RA from the American College of Rheumatology
were recently updated. The goal of treatment is to
minimize disease activity and prevent irreversible
joint damage.
Comparison Table: Some Lipid-Lowering Drugs (online only)
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022 (Issue 1659)
Lodalis colestipol Colestid cholestyramine Questran Olestyr Prevalite Lopid fenofibrate Lipitor ...
View the Comparison Table: Some Lipid-Lowering Drugs
Drugs for Psoriatic Arthritis
The Medical Letter on Drugs and Therapeutics • Dec 30, 2019 (Issue 1588)
Rinvoq Renflexis Metoject Neoral NSAIDs Olestyr Orencia Otezla Otrexup Psoriatic arthritis Questran ...
Psoriatic arthritis is a chronic inflammatory
arthropathy associated with psoriasis. A recent review
found that about 20% of patients with psoriasis have
psoriatic arthritis. Updated guidelines for treatment
of psoriatic arthritis have recently been published.
Lipid-Lowering Drugs
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022 (Issue 1659)
. Evinacumab (Evkeeza) for homozygous familial hypercholesterolemia.
Med Lett Drugs Ther 2021; 63:66. Olestyr ...
Cholesterol management guidelines from the
American College of Cardiology/American Heart
Association Task Force were last published in 2019.